• 3298 Citations
  • 32 h-Index
1979 …2019
If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Renato Maserati is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 66 Similar Profiles
HIV Medicine & Life Sciences
HIV-1 Medicine & Life Sciences
Highly Active Antiretroviral Therapy Medicine & Life Sciences
efavirenz Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
HIV Infections Medicine & Life Sciences
Tenofovir Medicine & Life Sciences
Progressive Multifocal Leukoencephalopathy Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1979 2019

  • 3298 Citations
  • 32 h-Index
  • 193 Article
  • 2 Chapter
  • 1 Letter
  • 1 Review article

Prevalence of acquired resistance mutations in a large cohort of perinatally infected HIV-1 patients

Ungaro, R., Taramasso, L., Bruzzone, B., Vicenti, I., Galli, L., Borghi, V., Francisci, D., Pecorari, M., Zoncada, A., Callegaro, A. P., Paolini, E., Monno, L., Bonora, S., Di Biagio, A., Giacometti, A., Butini, L., del Gobbo, R., Bagnarelli, P., Tacconi, D., Corbelli, G. & 30 others, Zanussi, S., Monno, L., Punzi, G., Maggiolo, F., Calza, L., Carla Re, M., Pristera, R., Turconi, P., Mandas, A., Tini, S., Zoncada, A., Paolini, E., Amadio, G., Sighinolfi, L., Corsi, P., Galli, L., Di Pietro, M., Colao, G., Biondi, M. L., Maserati, R., Filice, G., Baldanti, F., Magnani, G., Palmisano, L., Antinori, A., Zaccarelli, M., De Luca, A., Rossi, C., Grossi, P. & Seminari, E., Nov 1 2019, In : Clinical Microbiology and Infection. 25, 11, p. 1443-1446 4 p.

Research output: Contribution to journalLetter

Open Access
Hepacivirus
Antiviral Agents
Genotype
RNA
Treatment Failure
1 Citation (Scopus)

A comprehensive development agenda on tenofovir alafenamide in clinical practice

Di Biagio, A., Riccardi, N., Rusconi, S., Guaraldi, G., Borderi, M., De Luca, A., Gianotti, N., Lo Caputo, S., Maggi, P., Maserati, R. & Maggiolo, F., Apr 1 2018, In : AIDS Reviews. 20, 2, p. 75-82 8 p.

Research output: Contribution to journalReview article

Tenofovir
HIV-1
Budgets
Developed Countries
Tablets
3 Citations (Scopus)

Dolutegravir (DTG)-containing regimens after receiving raltegravir (RAL) or elvitegravir (EVG): Durability and virological response in a large Italian HIV drug resistance network (ARCA)

on behalf of ARCA (Antiviral Response Cohort Analysis), Aug 1 2018, In : Journal of Clinical Virology. 105, p. 112-117 6 p.

Research output: Contribution to journalArticle

Drug Resistance
HIV
HIV-1
RNA
JTK 303
8 Citations (Scopus)

Impact of the M184V resistance mutation on virological efficacy and durability of lamivudine-based dual antiretroviral regimens as maintenance therapy in individuals with suppressed HIV-1 RNA: A cohort study

Gagliardini, R., Ciccullo, A., Borghetti, A., Maggiolo, F., Bartolozzi, D., Borghi, V., Pecorari, M., Di Biagio, A., Callegaro, A. P., Bruzzone, B., Saladini, F., Paolucci, S., Maserati, R., Zazzi, M., Di Giambenedetto, S. & De Luca, A., Jan 1 2018, In : Open Forum Infectious Diseases. 5, 6, p. 1-8 8 p.

Research output: Contribution to journalArticle

Lamivudine
HIV-1
Cohort Studies
RNA
Mutation